# FDA Inspection 1159812 - Sarepta Therapeutics, Inc. - December 06, 2021

Source: https://www.keypedia.com/records/fda_inspections/sarepta-therapeutics-inc/3383558b-18c2-4bbf-9116-63e1f29b3109
Source feed: FDA_Inspections

> FDA Inspection 1159812 for Sarepta Therapeutics, Inc. on December 06, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1159812
- Company Name: Sarepta Therapeutics, Inc.
- Inspection Date: 2021-12-06
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1091489 - 2019-04-18](https://www.keypedia.com/records/fda_inspections/sarepta-therapeutics-inc/db39babc-8fc5-43fb-93e9-fd4d5b4bc46e)
- [FDA Inspection 1048077 - 2018-04-12](https://www.keypedia.com/records/fda_inspections/sarepta-therapeutics-inc/f4d7c881-87b3-4792-91f5-b556fe3f0046)

Company: https://www.keypedia.com/companies/sarepta-therapeutics-inc/e8742d5e-ca73-4f13-bc9f-d8b4a7b0875e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c